Cervical Cancer Screening Market opportunities are expanding through the integration of HPV DNA testing into national screening guidelines. The shift toward molecular testing is supporting more accurate identification of high-risk HPV strains and strengthening preventive healthcare strategies. The Cervical Cancer Screening Market is expected to reach US$ 10,678 million by 2031, registering a...